ORTOMA AB B (82Y) - Net Assets
Based on the latest financial reports, ORTOMA AB B (82Y) has net assets worth €142.72 Million EUR (≈ $166.85 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€161.34 Million ≈ $188.62 Million USD) and total liabilities (€18.63 Million ≈ $21.78 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Read total liabilities of ORTOMA AB B for a breakdown of total debt and financial obligations.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €142.72 Million |
| % of Total Assets | 88.46% |
| Annual Growth Rate | 2.35% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 26.96 |
ORTOMA AB B - Net Assets Trend (2021–2025)
This chart illustrates how ORTOMA AB B's net assets have evolved over time, based on quarterly financial data. Also explore 82Y total assets for the complete picture of this company's asset base.
Annual Net Assets for ORTOMA AB B (2021–2025)
The table below shows the annual net assets of ORTOMA AB B from 2021 to 2025. For live valuation and market cap data, see how much is ORTOMA AB B worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €142.72 Million ≈ $166.85 Million |
-11.85% |
| 2024-12-31 | €161.91 Million ≈ $189.29 Million |
-6.70% |
| 2023-12-31 | €173.54 Million ≈ $202.88 Million |
+51.84% |
| 2022-12-31 | €114.29 Million ≈ $133.62 Million |
-12.11% |
| 2021-12-31 | €130.04 Million ≈ $152.03 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to ORTOMA AB B's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 43.7% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €18.57 Million | 13.02% |
| Other Components | €124.14 Million | 86.98% |
| Total Equity | €142.72 Million | 100.00% |
ORTOMA AB B Competitors by Market Cap
The table below lists competitors of ORTOMA AB B ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
HeraMED Limited
F:1I4
|
$26.40 Million |
|
ABVC Biopharma Inc
NASDAQ:ABVC
|
$26.41 Million |
|
Vibhor Steel Tubes Limited
NSE:VSTL
|
$26.41 Million |
|
Plantynet Co. Ltd
KQ:075130
|
$26.41 Million |
|
Reka Industrial Oyj
HE:REKA
|
$26.39 Million |
|
Investcorp Credit Management BDC Inc
NASDAQ:ICMB
|
$26.39 Million |
|
Mundoro Capital Inc
V:MUN
|
$26.39 Million |
|
Armidian Karyatama Tbk PT
JK:ARMY
|
$26.39 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in ORTOMA AB B's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 161,907,935 to 142,715,022, a change of -19,192,913 (-11.9%).
- Net loss of 19,192,912 reduced equity.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-19.19 Million | -13.45% |
| Other Changes | €-1.00 | -0.0% |
| Total Change | €- | -11.85% |
Book Value vs Market Value Analysis
This analysis compares ORTOMA AB B's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.18x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | €5.49 | €0.68 | x |
| 2022-12-31 | €4.82 | €0.68 | x |
| 2023-12-31 | €4.68 | €0.68 | x |
| 2024-12-31 | €4.37 | €0.68 | x |
| 2025-12-31 | €3.85 | €0.68 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently ORTOMA AB B utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -13.45%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -29.69%
- • Asset Turnover: 0.40x
- • Equity Multiplier: 1.13x
- Recent ROE (-13.45%) is below the historical average (-11.06%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | -8.30% | 0.00% | 0.00x | 1.03x | €-23.79 Million |
| 2022 | -13.78% | 0.00% | 0.00x | 1.32x | €-27.18 Million |
| 2023 | -12.60% | -57.35% | 0.20x | 1.11x | €-39.23 Million |
| 2024 | -7.18% | -23.68% | 0.27x | 1.12x | €-27.82 Million |
| 2025 | -13.45% | -29.69% | 0.40x | 1.13x | €-33.46 Million |
Industry Comparison
This section compares ORTOMA AB B's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $1,138,040,535
- Average return on equity (ROE) among peers: -31.97%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| ORTOMA AB B (82Y) | €142.72 Million | -8.30% | 0.13x | $26.39 Million |
| HeraMED Limited (1I4) | $2.77 Million | -198.14% | 0.62x | $26.40 Million |
| Medtronic PLC (2M6) | $796.50 Million | 20.28% | 0.46x | $102.18 Billion |
| Peijia Medical Limited (4WO) | $2.64 Billion | -15.46% | 0.26x | $403.65 Million |
| AVITA Medical Inc (51KB) | $20.86 Million | -118.03% | 0.23x | $172.49 Million |
| MICROPORT CARDIO.MEDTECH. (72X) | $2.33 Billion | -20.20% | 0.10x | $107.57 Million |
| MODULIGHT OY EO 1 (78W) | $44.68 Million | -10.30% | 0.10x | $43.97 Million |
| ACOTEC SCIEN.H. DL-00001 (7W3) | $1.35 Billion | 3.87% | 0.23x | $377.38 Million |
| LIFETECH SCI.DL-00000125 (81X) | $2.92 Billion | 11.14% | 0.26x | $893.41 Million |
| COPLAND ROAD CAPITAL NEW (A2P) | $134.20 Million | 39.08% | 1.23x | $594.67 Million |
About ORTOMA AB B
Ortoma AB (publ) provides orthopedic surgical products in Sweden. It offers Ortoma Treatment Solution (OTS), an orthopedic digital, server-based integrated AI platform designed to optimize patient outcomes through surgical planning, precision surgical navigation, post-operative verification, and follow-up; OTS Plan, a software that processes and assists surgeons during pre-operative planning and … Read more